Bell Investment Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01K Sell
10
-53
-84% -$5.49K ﹤0.01% 1529
2026
Q1
$6.09K Buy
63
+53
+530% +$5.43K ﹤0.01% 884
2025
Q4
$1.06K Sell
10
-4
-29% -$464 ﹤0.01% 1530
2025
Q3
$1.78K Buy
14
+4
+40% +$476 ﹤0.01% 1371
2025
Q2
$1.23K Hold
10
– – ﹤0.01% 1528
2025
Q1
$1.01K Hold
10
– – ﹤0.01% 1544
2024
Q4
$924 Hold
10
– – ﹤0.01% 1612
2024
Q3
$967 Sell
10
-6
-38% -$539 ﹤0.01% 1603
2024
Q2
$1.37K Buy
16
+6
+60% +$504 ﹤0.01% 1507
2024
Q1
$826 Hold
10
– – ﹤0.01% 1654
2023
Q4
$668 Hold
10
– – ﹤0.01% 1713
2023
Q3
$672 Hold
10
– – ﹤0.01% 1678
2023
Q2
$678 Hold
10
– – ﹤0.01% 1702
2023
Q1
$541 Buy
10
+1
+11% +$58 ﹤0.01% 1787
2022
Q4
$538 Buy
+9
New +$489 ﹤0.01% 1784
2021
Q4
$3K Buy
63
+55
+688% +$2.84K ﹤0.01% 965
2021
Q3
$0 Buy
+8
New +$503 ﹤0.01% 1744

Other funds holding EHC

Bell Investment Advisors's EHC Position: Q2 2026 in Review

Bell Investment Advisors reduced its Encompass Health (EHC) stake by 84% in Q2 2026, selling an estimated $5.49K and leaving 10 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Bell Investment Advisors first reported a position in EHC in Q3 2021 and has held it in 17 quarters since. The position peaked at $6.09K in Q1 2026. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Bell Investment Advisors held 10 shares of Encompass Health worth $1.01K as of Q2 2026.
  • Bell Investment Advisors sold 53 Encompass Health shares in Q2 2026, an estimated $5.49K.
  • Encompass Health made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1529 holding.
  • Bell Investment Advisors first reported a position in Encompass Health in Q3 2021 and has held it in 17 quarters since.
  • Bell Investment Advisors's Encompass Health position peaked at $6.09K in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.